Keywords: fda, approves, novartis, gleevec, gist, food, drug

FDA approves Novartis' Gleevec for GIST

Article | 12 January 2009

Print This

The US Food and Drug Administration has extended the indication of Swiss drug major Novartis' Gleevec (imatinib mesylate) to include ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in